Medical Biochemistry and Metabolomics articles for United Kingdom (UK)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 100

Article ‘Count’ for Medical Biochemistry and Metabolomics.

Journal Count Share
4 1.29
Circulating saturated fatty acids and incident chronic kidney disease: a meta-analysis of de-novo prospective cohort investigations 0.07
High concentrations of polyunsaturated n–3 fatty acids in serum are inversely associated with risk of future incident venous thromboembolism – the HUNT cohort study 0.27
New insights into total and resting energy expenditure using state-of-the-art methods in cancer survivors: a cross-sectional study 0.17
The effects of consumption of interesterified fats rich in palmitic acid versus stearic acid on intermediary markers of cardiometabolic disease risk: a randomized controlled trial in healthy adults. 0.78
2 0.94
Genetic regulation of fatty acid content in adipose tissue 0.89
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunction 0.05
1 0.05
Live-Cell Imaging and Lipidomics of Low-Density Lipoprotein Containing Intrinsically Fluorescent Cholesteryl Esters 0.05
3 1.99
Computer Vision Enables Monitoring and Kinetic Analysis of Structurally Diverse Carbon Monoxide Surrogates 1.00
A Cathepsin B-Triggered CO-Releasing Molecule with a Non-Toxic Metal Core for Targeted Tumor Delivery 0.19
A Single‐Molecule Liposome Assay for Membrane Permeabilization 0.80
1 0.03
Cross‐Sectional scpFDG/scp in Down Syndrome and Autosomal Dominant Alzheimer's Disease 0.03
1 0.11
Bile acids metabolism in symptomatic hand osteoarthritis 0.11
1 0.33
PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer 0.33
1 0.03
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma 0.03
1 0.01
Mitochondrial metabolism regulates the immunogenic responsiveness of dendritic cells 0.01
1 0.05
SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure 0.05
1 1.00
Sex-specific body fat distribution predicts cardiovascular ageing 1.00
2 0.07
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement 0.06
Targeting Treg–fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinoma 0.02
1 0.07
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD. 0.07
1 0.80
The relationship between polyunsaturated fatty acids and inflammation: evidence from cohort and Mendelian randomization analyses 0.80
4 2.69
Genetic risk, antiseizure medications, and lifestyle factors in epilepsy-associated obesity and overweight 0.07
Relationship between the microbiome and obesity-associated cancer risk using Mendelian randomisation 1.00
Body mass index and infection risks in people with and without type 2 diabetes: A cohort study using electronic health records 1.00
Changes in abdominal subcutaneous adipose tissue thickness associate with disease and anthropometric factors 0.63
3 1.23
Structural and functional consequences of aspartate/asparagine-β-hydroxylase variants causing Traboulsi Syndrome 1.00
Neurodevelopmental Disease-causing Variants in Choline Kinase CHKA Gene Couple Phosphatidylcholine Synthesis to Oxidative Stress Damage and Disease Etiology 0.17
The serine protease HTRA1 targets tau fibrils and provides a proteolytic barrier against pathogenic protein conformations 0.07
2 1.59
Protein Kinase C promotes peroxisome biogenesis and peroxisome–endoplasmic reticulum interaction 0.60
Metabolic adaptations of micrometastases alter EV production to generate invasive microenvironments 0.99
3 1.76
Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy 1.00
Multiomics of Human Obesity and Related Multisystem Diseases 0.01
The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort 0.75
2 0.36
Biallelic GLTP mutations cause nonsyndromic epidermal differentiation disorder via disrupted epidermal glucosylceramide transport 0.27
Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain proteins hypersialylation 0.08
2 0.38
Somatic loss-of-function mutations in CIDEB reduce hepatic steatosis by increasing lipolysis and fatty acid oxidation 0.28
Phase 1 randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction–associated steatohepatitis 0.10
2 0.60
Dynamic Shape Modulation of Deflated and Adhered Lipid Vesicles 0.17
Organic Carbon Monoxide Prodrugs Activated by Endogenous Reactive Oxygen Species for Targeted Delivery 0.43
1 0.45
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis 0.45
2 0.71
MEDAG functions as an A-kinase-anchoring protein in adipocytes 0.05
Rapid remodeling of NTP levels enables immediate translational adaptation to energy stress in yeast 0.67
1 0.50
From Shallow to Full Wrapping: Geometry and Deformability Dictate Lipid Vesicle Internalization 0.50
9 2.68
A deep-learning framework reveals whole-body perturbations at cell level 0.02
Proteasome-guided haem signalling axis contributes to T cell exhaustion 0.06
CLCC1 promotes hepatic neutral lipid flux and nuclear pore complex assembly 0.04
ZFTA–RELA ependymomas make itaconate to epigenetically drive fusion expression 0.02
Genetic suppression features as a Barth syndrome therapeutic target 0.06
Mitochondrial origins of the pressure to sleep 1.00
Selective remodelling of the adipose niche in obesity and weight loss 0.99
Allosteric modulation and biased signalling at free fatty acid receptor 2 0.45
Early life high fructose impairs microglial phagocytosis and neurodevelopment 0.04
2 1.44
Intracrine FFA4 signaling controls lipolysis at lipid droplets 0.76
Lipoyl deglutarylation by ABHD11 regulates mitochondrial and T cell metabolism 0.68
1 0.22
High-throughput discovery of fluoroprobes that recognize amyloid fibril polymorphs 0.22
19 6.73
Membrane lipid poly-unsaturation selectively affects dopamine D2 receptor endocytosis 0.05
Atomic structures of medin and Aβ fibrils reveal polymorphic remodeling in mixed amyloid systems 0.08
SPNS2 exports sphingosine-1-phosphate and imports glucose 0.13
An immunobiliary single-cell atlas resolves crosstalk between type 2 conventional dendritic cells and γδ T cells in cholangitis 0.02
Engineering synthetic cells with intramembrane domains possessing distinct bilayer asymmetries 0.13
Butyrate extends health and lifespan in mice with mitochondrial deficiency 0.04
Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD 0.03
Native chromatome profiling reveals hundreds of metabolic enzymes in the nucleus across tissues 0.07
Dynamic subcellular proteomics identifies regulators of adipocyte insulin action 1.00
Structural defects in amyloid-β fibrils drive secondary nucleation 0.26
Epoxy-oxylipins direct monocyte fate in inflammatory resolution in humans 0.82
Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis 0.21
Defective vascular smooth muscle cell tafazzin impairs mitochondrial function and promotes atherosclerosis in preclinical models 1.00
Plasma lipopolysaccharide levels predict mortality in acutely ill children in Low- and Middle-Income Countries 0.24
Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in parkinson’s disease brain 0.97
Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma 0.71
Autophagy acts as a brake on obesity-related fibrosis by controlling purine nucleoside signalling 0.78
Defective Olfactomedin-2 connects adipocyte dysfunction to obesity 0.14
Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structure 0.06
1 0.08
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage 0.08
2 0.84
Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk 0.70
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis 0.14
1 0.11
The blood–brain barrier regulates brain tumor growth through the SLC36 amino acid transporter Pathetic in Drosophila 0.11
6 1.54
Structural studies of an antinecroptosis viral:human functional heteroamyloid M45:RIPK3 using SSNMR 0.09
Reconstruction of human metabolic models with large language models 0.05
Tau catalyzes amyloid-β aggregation and toxicity in a polymorph-dependent manner 0.25
Sleep loss induces cholesterol-associated myelin dysfunction 0.02
Amyloid-β modulates the phase separation and aggregation of α-synuclein 1.00
An aminosterol breaks the autocatalytic cycle of Aβ42 aggregation and protects cell membranes from its soluble aggregates 0.13
2 0.26
Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity 0.05
ROS transfer at peroxisome-mitochondria contact regulates mitochondrial redox 0.21
7 2.62
PPT1 selectively depalmitoylates GAP43 to regulate neuronal excitability and cognitive function 0.08
Integrated analysis of insulin resistance reveals metabolic remodeling following diet switch–triggered calorie reduction 1.00
Steric repulsion counteracts ER–to–lipid droplet protein movement 0.20
Amyloid-β oligomers, curvilinear and annular assemblies, imaged by cryo-ET, cryo-EM, and AFM 0.86
Mechanism and cellular actions of the potent AMPK inhibitor BAY-3827 0.15
Cryogenic electron tomography reveals helical organization of lipoprotein lipase in storage vesicles 0.25
The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5 0.07
1 0.06
Retinal polyunsaturated fatty acid supplementation reverses aging-related vision decline in mice 0.06
2 1.03
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELY 1.00
Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study 0.03
1 0.86
Lipopolysaccharide confinement in the bacterial outer membrane is governed by interactions within the conserved Lipid A anchor 0.86
2 0.92
Disparities in diabetes treatment and monitoring for people with and without mental disorders: a systematic review and meta-analysis 0.13
Weight trajectories and access to weight management services in individuals with severe mental illness in the UK: a population-based, matched cohort study 0.79
1 0.06
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II 0.06

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.